This clinical-stage biotech develops bifunctional antibody therapies targeting solid tumors for oncology providers and ...

A Boston biotechnology company that abandoned plans to go public last year completed a successful initial public offering ...

Drug companies have cut nearly 69,000 pharmaceutical jobs since the start of 2021. A single biotech job posting now attracts ...

Yenssen Biotech opens international distributor recruitment for Dermlin wound healing series, Ulceloocin oral ulcer ...

MBC BioLabs sees its two biotech incubators location in San Francisco's Dogpatch neighborhood, near the AI hub of Mission Bay, as an advantage. It wants to build one more to prove the point.

According to him, the industry must address its relationship with the capital markets, address misinformation issues, and push back against the politicization of medical research and development.

Angelica Peebles, CNBC Health and Pharmaceutical Reporter, says U.S. drugmakers are accelerating China partnerships as ...

Hundreds of executives and investors are pushing for Rick Pazdur to be the next FDA commissioner. Elsewhere, Takeda detailed its latest restructuring and Alumis is discarding a once-highly touted ...

Aardvark Therapeutics is planning to unblind data from its phase 3 Prader-Willi syndrome (PWS) program after the FDA put a ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Diamantas takes the reins, Regenxbio stakes claim in Duchenne gene therapy, and more biotech news from The Readout ...

This week's episode of “The Readout LOUD” is all about health politics, including Marty Makary's departure as FDA ...